ClinicalTrials.Veeva

Menu

Minnesota RETAIN Phase 2 (sub-study) (MN RETAIN)

Mayo Clinic logo

Mayo Clinic

Status

Enrolling

Conditions

Disability
Illness Related Work
Injuries Related Work

Treatments

Other: RETAIN Program

Study type

Interventional

Funder types

Other

Identifiers

NCT05216016
OD-36365-21-75-4-27 (Other Grant/Funding Number)
21-006979

Details and patient eligibility

About

MN RETAIN Phase 2 Sub-study is a non-randomized trial to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Labor (US DOL) and sponsored jointly with the US Social Security Administration. There will be collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay-at-work and return-to-work. MN RETAIN involves a partnership between Mayo Clinic and MN Department of Employment and Economic Development (DEED), MN Department of Labor and Industry (DLI), MN Department of Health (MDH), Workforce Development, Inc. (WDI), and the Governor's Workforce Development Board. MN DEED serves as the main recipient and administrator of the funding within the state with Mayo Clinic, DLI, and WDI, as subrecipients of the grant.

(Effective Date: 12/23/2021-05/16/2024) MN RETAIN Phase 2 : This study is a randomized control trial (RCT) to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Labor (US DOL) and sponsored jointly with the US Social Security Administration. There will be collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay-at-work and return-to-work. MN RETAIN involves a partnership between Mayo Clinic and MN Department of Employment and Economic Development (DEED), MN Department of Labor and Industry (DLI), MN Department of Health (MDH), Workforce Development, Inc. (WDI), and the Governor's Workforce Development Board. MN DEED serves as the main recipient and administrator of the funding within the state with Mayo Clinic, DLI, and WDI, as subrecipients of the grant. During this Phase: additional collaborators: Mathematica Policy Research

Enrollment

5,200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • > 18-years-old

  • MN Resident

  • Works in MN

  • Employed at the time of enrollment

  • Within 6 months of last day of work

  • Meets one of the following:

    • Provider work restrictions of unable to work for at least 4 weeks
    • Per healthcare team anticipated to be unable to work for at least 4 weeks
    • Employer's inability to accommodate current work restrictions
  • Meets one of the following:

    • Diagnosis of a work related or personal injury or illness that impacts employment
    • Invasive procedure (e.g., surgery) anticipated within the next 4-weeks that impacts employment
  • Documentation of work restrictions (i.e., written note/form documentation in electronic medical record prior to enrollment)

Exclusion Criteria

  • Legal representation/litigation at the time of enrollment related to a workers' compensation medical condition
  • Does not have the capacity to give appropriate informed consent
  • Employed by a RETAIN healthcare recipient or subrecipient with an existing return to work program for employees (i.e., Mayo Clinic employees)
  • Workers' compensation recipients that have a qualified rehabilitation consultant (QRC) or a disability case manager (DCM)
  • Pending application OR Receiving Social Security Disability Insurance (SSDI) or Supplemental Security Income (SSI)
  • Self-Employed

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

5,200 participants in 3 patient groups

Control Group
No Intervention group
Description:
Individuals will receive a handout with additional job related services; e.g. Job Accommodation Network.
Intervention Group
Experimental group
Description:
Individuals will be assigned a dedicated Minnesota RETAIN Return-to-Work Case Manager. Intervention group participants will be referred for additional career and workforce development resources when needed.
Treatment:
Other: RETAIN Program
Sub Study Group
Experimental group
Description:
Individuals will be assigned a dedicated Minnesota RETAIN Return-to-Work Case Manager. Intervention group participants will be referred for additional career and workforce development resources when needed.
Treatment:
Other: RETAIN Program

Trial contacts and locations

1

Loading...

Central trial contact

Tammy Green, MBA; Samantha Westphal, RN, BSN, PHN, CLMS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems